10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-008373`
Period End Date	20170331
Filing Date	20170503
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	arwr-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 70 Cash Flow Statement 60 Stockholders Equity 16

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$61.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$50.30M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$580.83K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$75.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.29M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$731.83K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.77M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.75M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.77M	shares	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$24.91M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	69.75M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.77M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$89.69M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	69.75M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$90.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.71M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.39M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$21.31M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$22.16M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$122.33K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$152.12K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$128.18M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$126.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.23M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.18M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.59M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$765.29K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.97M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$440.58K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$440.58K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$2.57M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$21.17M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.60M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$146.18K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$194.31K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$201.25K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$27.55M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$25.64M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$2.10M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$2.27M	USD	Point-in-time
Deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$1.25M	USD	Point-in-time
Deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$2.50M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.43M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.53M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$7.51M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$5.98M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 and 15,652 shares issued and outstanding as of March 31, 2017 and September 30, 2016	`PreferredStockValue`	$16.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 74,772,103 and 69,746,685 shares issued and outstanding as of March 31, 2017 and September 30, 2016, respectively	`CommonStockValue`	$162.12K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 74,772,103 and 69,746,685 shares issued and outstanding as of March 31, 2017 and September 30, 2016, respectively	`CommonStockValue`	$167.14K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$510.32M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$493.84M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$7.45K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.70K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-398.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-416.56M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$95.58M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$93.89M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.02M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$93.34M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$128.18M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$126.87M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$13.35M	USD	2 Qtrs
REVENUE	`Revenues`	$8.99M	USD	1 Quarter
REVENUE	`Revenues`	$87.50K	USD	2 Qtrs
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.98M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$10.02M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$16.50M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$20.36M	USD	2 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$4.25M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$8.17M	USD	2 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$7.86M	USD	2 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.58M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.48M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.77M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.82M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.62M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$4.80M	USD	2 Qtrs
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$2.42M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$4.17M	USD	2 Qtrs
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$1.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.19M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$803.91K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.37M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.60M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$34.38M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$21.31M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$40.69M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$15.12M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-40.61M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-21.03M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-21.26M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-6.13M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$108.74K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$79.06K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$179.44K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$133.89K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$369.94K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-27.38K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$346.41K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.46M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.31M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$5.72K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$525.85K	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.90M	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$87.08K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$449.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-20.82M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.04M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-18.13M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.08M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-6.04M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-20.82M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-40.08M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-18.13M	USD	2 Qtrs
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.67	USD	2 Qtrs
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.25	USD	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	74.63M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.78M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.66M	shares	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	73.02M	shares	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$154.46K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$196.34K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$150.52K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-38.14K	USD	2 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-18.17M	USD	2 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-5.89M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-39.88M	USD	2 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-20.67M	USD	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-6.04M	USD	1 Quarter
Net loss	`ProfitLoss`	$-20.82M	USD	1 Quarter
Net loss	`ProfitLoss`	$-40.08M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-18.13M	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$369.94K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-27.38K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$346.41K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.46M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.17M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.80M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.19M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$803.91K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.37M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.60M	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-179.46K	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$64.39K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$505.82K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$25.16K	USD	2 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.52M	USD	2 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$616.68K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$17.31M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-37.50K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.51M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.99M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.07M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-5.42M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-139.45K	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$190.28K	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-35.90M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.33M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.65M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$500.63K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$24.85M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.20M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$5.70M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-31.50M	USD	2 Qtrs
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$108.33K	USD	2 Qtrs
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$97.14K	USD	2 Qtrs
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$417.14K	USD	2 Qtrs
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$634.19K	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$12.69M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.54K	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-716.97K	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$12.18M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-30.91M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-23.65M	USD	2 Qtrs
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$61.72M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$50.30M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$61.72M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$50.30M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
Interest Paid	`InterestPaid`	$95.54K	USD	2 Qtrs
Interest Paid	`InterestPaid`	$5.80K	USD	2 Qtrs
Income Tax Credits Refunded	`ProceedsFromRefundableIncomeTaxCredits`	$1.37M	USD	2 Qtrs
Income Tax Credits Refunded	`ProceedsFromRefundableIncomeTaxCredits`	$3.64M	USD	2 Qtrs
Income Tax Paid	`IncomeTaxesPaid`	$2.40K	USD	2 Qtrs
Income Tax Paid	`IncomeTaxesPaid`	$2.40K	USD	2 Qtrs

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.02M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$93.34M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.17M	USD	2 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$271.93K	USD	2 Qtrs
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	135,730.00	shares	2 Qtrs
Common stock- Restricted Stock Units vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-381.56K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$154.46K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$196.34K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$150.52K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-38.14K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-6.04M	USD	1 Quarter
Net loss	`ProfitLoss`	$-20.82M	USD	1 Quarter
Net loss	`ProfitLoss`	$-40.08M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-18.13M	USD	2 Qtrs
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.02M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$93.34M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.